[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352787-105":59,"doc-detail-352787-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","association-of-idh1-mutations-with-survival-and-recurrence-in-resected-intrahepatic-cholangiocarcinoma-original-article","Association of IDH1 mutations with survival and recurrence in resected intrahepatic cholangiocarcinoma - Original Article","","IDH1 mutations drive tumor development, yet their relationship to clinicopathologic features, prognosis, and response to therapy in patients with resected intrahepatic cholangiocarcinoma (ICC) remains unresolved. This single-hospital cohort study enrolled 803 ICC patients undergoing curative resection. Whole-exome and Sanger sequencing identified IDH1 mutations, with Kaplan–Meier and log-rank methods assessing overall survival (OS) and disease-free survival (DFS).",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/association-of-idh1-mutations-with-survival-and-recurrence-in-resected-intrahepatic-cholangiocarcinoma-original-article/352787/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/association-of-idh1-mutations-with-survival-and-recurrence-in-resected-intrahepatic-cholangiocarcinoma-original-article/352787.png","ImageObject",300,407,{"name":92,"@type":93},"Angel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What patient population was analyzed in this study?","Question",{"text":112,"@type":113},"The study included 803 patients who underwent curative resection for intrahepatic cholangiocarcinoma (ICC) at a single hospital in China.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were IDH1 mutations detected?",{"text":117,"@type":113},"IDH1 mutations were identified using whole-exome sequencing and Sanger sequencing.",{"name":119,"@type":110,"acceptedAnswer":120},"What was the study’s main finding regarding IDH1 mutations and adjuvant chemotherapy?",{"text":121,"@type":113},"In patients with resected ICC who received adjuvant chemotherapy, IDH1 mutations were associated with better overall survival and a decreased risk of recurrence.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352787,1790844785,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},687207412472,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","The Oncologist, 2026, 31, oyag124  \n[https://doi.org/10.1093/oncolo/oyag124](https://doi.org/10.1093/oncolo/oyag124)  \n[Published: April 7](Published: April 7), 2026  \nOriginal Article  \nAssociation of IDH1 mutations with survival and recurrence in resected intrahepatic cholangiocarcinoma received or not received adjuvant chemotherapy  \nPengcheng Wang1,2,3,†, Ning Li†,1,2, Yuhang Ye†,1,2, Jing Pu1,2, Rongqi Sun1,2, Chubin Luo1,2, Zhiqiang Hu1,2, Zhengjun Zhou2, Jia Li1,2, Jixue Zou4, Jia Fan1,2, Jian Zhou1,2, Shaolai Zhou*,1,2,   \n1 Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai 200032, China 2 Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China  \n3 Institute for Ovarian Cancer, Fudan University & Department of Gynecologic Oncology, Cancer Center, Fudan University Zhongshan Hospital, Shanghai 200032, China  \n4 Department of Hepatic Oncology, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China † Pengcheng Wang, Ning Li, and Yuhang Ye contributed equally to this work.  \n*Corresponding author: Shaolai Zhou, Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, 1609 Xie Tu Road, Shanghai 200032, China ([zhoushaolai99@sina.com](zhoushaolai99@sina.com)) .  \nAbstract  \nBackground: IDH1 mutations are causal in tumor development and progression; however, their association with disease characteristics, prognosis, and therapy response in patients with resected intrahepatic cholangiocarcinoma (ICC) remains controversial. Materials and Methods: In this cohort study, we recruited 803 patients who underwent curative resection for ICC at a single hospital in China. We performed whole-exome sequencing and Sanger sequencing to identify IDH1 mutations. We used the Kaplan–Meier method and log-rank test to compare overall survival (OS) and disease-free survival (DFS).  \nResults: A total of 5 different subtypes of IDH1 somatic mutation affecting 94 (11.7%) patients were identified. R132C was the most frequent mutant allele in this cohort, followed by R132L and R132G. Across all patients considered, those that received adjuvant chemotherapy had significantly superior OS and DFS compared with those that did not receive adjuvant chemotherapy. In the whole ICC cohort, patients with IDH1 mutations showed no significant difference in OS compared with patients with wild-type IDH1. When we looked at patients that either received or did not receive adjuvant chemotherapy separately, univariate and multivariable analyses revealed that IDH1 mutations were significantly associated with superior OS among patients that received adjuvant chemotherapy, whereas they were marginally associated with worse OS among patients that did not receive adjuvant chemotherapy.  \nConclusion: We characterized the distribution of IDH1 mutations in a large cohort of patients with ICC from China. The presence of IDH1 mutations was associated with better survival and decreased risk of recurrence in patients with resected ICC that received adjuvant chemotherapy.  \nKey words: Intrahepatic cholangiocarcinoma; IDH1; mutation; chemotherapy; prognosis  \nImplications for Practice  \nOur study shows that the presence of IDH1 mutations was associated with better survival and decreased risk of recurrence in resected ICC received adjuvant chemotherapy, which can help to guide precise adjuvant therapy for ICC patients after curative resection. These findings can help to guide precise adjuvant therapy for patients with ICC after curative resection.  \nIntroduction  \nIntrahepatic cholangiocarcinoma (ICC) is the second most common primary liver cancer and has an increasing incidence  \nworldwide, accounting for 20% of all cholangiocarcinomas.1,2 Characterized by high invasiveness and frequent postoperative recurrence, ICC exhibits one of the highest mortality rates  \nReceived: July 31, 2025. Accepted: March 30, 2026  \n© The Author(s)","cbCaifACmblzU4QL","https://ap.wps.com/l/cbCaifACmblzU4QL","pdf",1419324,"English","# Abstract\n## Background\n## Materials and Methods\n## Results\n## Conclusion\n# Implications for Practice\n# Introduction","[{\"question\":\"What patient population was analyzed in this study?\",\"answer\":\"The study included 803 patients who underwent curative resection for intrahepatic cholangiocarcinoma (ICC) at a single hospital in China.\"},{\"question\":\"How were IDH1 mutations detected?\",\"answer\":\"IDH1 mutations were identified using whole-exome sequencing and Sanger sequencing.\"},{\"question\":\"What was the study’s main finding regarding IDH1 mutations and adjuvant chemotherapy?\",\"answer\":\"In patients with resected ICC who received adjuvant chemotherapy, IDH1 mutations were associated with better overall survival and a decreased risk of recurrence.\"}]","Association of IDH1 mutations with survival and recurrence in resected intrahepatic cholangiocarcinoma - Original Article | PDF",1790101375,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9d1cf1c182d7830ef6193a032a9f03e4.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a2ae3dbe1a4710d56d67d9fb51443038.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6eea1ae22645f4f4b6c9abe45cee20ac.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d35ea4987b7c6f64a4c8f5356ee3ceb1.webp",980,1287]